Xin yixue (Oct 2023)

Advances in Chinese medicine-mediated AMPK/mTOR signaling pathway for the treatment of osteoporosis

  • Zhang Wenhao, Yi Lin, Xiang Wenyuan, Remira·Aimaiti, Deng Yingjie, Liao Jun, Liang Zhiquan, Li Leijiang, Fang Rui

DOI
https://doi.org/10.3969/j.issn.0253-9802.2023.10.003
Journal volume & issue
Vol. 54, no. 10
pp. 704 – 707

Abstract

Read online

Osteoporosis （OP） is a systemic bone disease and a common orthopedic disorder in elderly patients. High morbidity， disability and mortality rates and medical cost of OP bring huge burden to the patients and their family. Serine/threonine protein kinase（AMPK）/ mammalian target of rapamycin （mTOR） signaling pathway plays a significant role in cell metabolism and apoptosis. Traditional Chinese medicine monomer or compound can prevent and treat OP by regulating the expression levels of related factors through the AMPK/mTOR signaling pathway， whereas the specific mechanism remains elusive. In this article， the effect of AMPK/mTOR signaling pathway upon osteoblasts and osteoclasts， and the regulatory role of traditional Chinese medicine were reviewed， aiming to provide novel perspectives and ideas for prevention and treatment of OP.

Keywords